This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ishimitsu, T. Articles by Sugimoto, T. Search for Related Content PubMed PubMed Citation Articles by Ishimitsu, T. Articles by Sugimoto, T. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure

Hypertension, Vol 12, 46-51, Copyright © 1988 by American Heart Association

ARTICLES

Thromboxane and vascular smooth muscle cell growth in genetically hypertensive rats

T Ishimitsu, Y Uehara, M Ishii, T Ikeda, H Matsuoka and T Sugimoto
2nd Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

The vascular wall has the capacity to produce thromboxane A2. However, the role of vascular thromboxane A2 is still uncertain. In this study, we examined the relationship between vascular thromboxane A2 generation and vascular smooth muscle cell growth in spontaneously hypertensive rats (SHR). Vascular thromboxane A2 generation was significantly enhanced by 49% in 5-week-old and by 117% in 15-week-old SHR as compared with age-matched Wistar-Kyoto rats (WKY). Thromboxane A2 generation was also significantly enhanced by 59% in the cultured vascular smooth muscle cells of SHR when compared with production in WKY. Vascular smooth muscle cells of SHR exhibited a significantly shortened doubling time (by 32%) and greater [3H]thymidine uptake (by 56%), as compared with those of WKY. OKY 046 (10(-5) M), a thromboxane synthase inhibitor, significantly tempered the rapid vascular smooth muscle cell growth in SHR by 9% for doubling time and by 10% for [3H]thymidine uptake. OKY 046 did not influence the doubling time of WKY. Conversely, a stable analogue of thromboxane A2 dose-dependently stimulated the [3H]thymidine uptake by vascular smooth muscle cells of WKY, and, at a concentration of 10(-5) M, shortened the doubling time of vascular smooth muscle cells of WKY by 11%, whereas it showed slight effects on SHR. These data indicate that vascular thromboxane A2 is involved in the regulatory mechanism of vascular smooth muscle cell growth and that enhanced vascular thromboxane A2 generation is partly responsible for the rapid proliferation of vascular smooth muscle cells of SHR. The alterations of vascular thromboxane production may be a key trait for genetic hypertension.

This article has been cited by other articles:

				J. Zicha and J. Kunes Ontogenetic Aspects of Hypertension Development: Analysis in the Rat Physiol Rev, October 1, 1999; 79(4): 1227 - 1282. [Abstract] [Full Text] [PDF]

				R. Pakala, J. T. Willerson, and C. R. Benedict Effect of Serotonin, Thromboxane A2, and Specific Receptor Antagonists on Vascular Smooth Muscle Cell Proliferation Circulation, October 7, 1997; 96(7): 2280 - 2286. [Abstract] [Full Text]

				F. N. Ko Low-Affinity Thromboxane Receptor Mediates Proliferation in Cultured Vascular Smooth Muscle Cells of Rats Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1274 - 1282. [Abstract] [Full Text]

				P. A. Craven, R. K. Studer, and F. R. DeRubertis Thromboxane/Prostaglandin Endoperoxide–Induced Hypertrophy of Rat Vascular Smooth Muscle Cells Is Signaled by Protein Kinase C–Dependent Increases in Transforming Growth Factor-ß Hypertension, August 1, 1996; 28(2): 169 - 176. [Abstract] [Full Text]

				A. Sachinidis, M. Flesch, Y. Ko, K. Schror, M. Bohm, R. Dusing, and H. Vetter Thromboxane A2 and Vascular Smooth Muscle Cell Proliferation Hypertension, November 1, 1995; 26(5): 771 - 780. [Abstract] [Full Text]

				T. Ge, H. Hughes, D. C. Junquero, K. K. Wu, P. M. Vanhoutte, and C. M. Boulanger Endothelium-Dependent Contractions Are Associated With Both Augmented Expressionof Prostaglandin H Synthase-1 and Hypersensitivity to Prostaglandin H2in the SHR Aorta Circ. Res., June 1, 1995; 76(6): 1003 - 1010. [Abstract] [Full Text]